Trxade Group Inc

Company Profile

Trxade Group Inc had its IPO on 2010-04-27 under the ticker symbol MEDS.

The company operates in the Healthcare sector and Pharmaceutical Retailers industry. Trxade Group Inc has a staff strength of 33 employees.

Stock update

Shares of Trxade Group Inc opened at $10.43 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $9.26 - $10.55, and closed at $9.69.

This is a -8.24% slip from the previous day's closing price.

A total volume of 66,938 shares were traded at the close of the day’s session.

In the last one week, shares of Trxade Group Inc have slipped by -16.61%.

Trxade Group Inc's Key Ratios

Trxade Group Inc has a market cap of $14.49 million, indicating a price to book ratio of 4.621 and a price to sales ratio of 0.5246.

In the last 12-months Trxade Group Inc’s revenue was $9.43 million with a gross profit of $4.58 million and an EBITDA of $-2256562. The EBITDA ratio measures Trxade Group Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Trxade Group Inc’s operating margin was -23.9% while its return on assets stood at -29.91% with a return of equity of -1620.51%.

In Q2, Trxade Group Inc’s quarterly earnings growth was a positive 276.6% while revenue growth was a negative 31.3%.

Trxade Group Inc’s PE and PEG Ratio

Forward PE

21.8341

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-5.63 per share while it has a forward price to earnings multiple of 21.8341 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Trxade Group Inc’s profitability.

Trxade Group Inc stock is trading at a EV to sales ratio of 0.6873 and a EV to EBITDA ratio of -2.5578. Its price to sales ratio in the trailing 12-months stood at 0.5246.

Trxade Group Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$3.74 million

Total Liabilities

$4.26 million

Operating Cash Flow

$0

Capital Expenditure

$51803

Dividend Payout Ratio

0%

Trxade Group Inc ended 2024 with $3.74 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.74 million while shareholder equity stood at $-1294527.00.

Trxade Group Inc ended 2024 with $0 in deferred long-term liabilities, $4.26 million in other current liabilities, 7.00 in common stock, $-21880337.00 in retained earnings and $0 in goodwill. Its cash balance stood at $745561.00 and cash and short-term investments were $745561.00. The company’s total short-term debt was $211,427 while long-term debt stood at $0.

Trxade Group Inc’s total current assets stands at $2.10 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $799436.00 compared to accounts payable of $863579.00 and inventory worth $161259.00.

In 2024, Trxade Group Inc's operating cash flow was $0 while its capital expenditure stood at $51803.

Comparatively, Trxade Group Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$9.69

52-Week High

$22.5

52-Week Low

$3.765

Analyst Target Price

$6.75

Trxade Group Inc stock is currently trading at $9.69 per share. It touched a 52-week high of $22.5 and a 52-week low of $22.5. Analysts tracking the stock have a 12-month average target price of $6.75.

Its 50-day moving average was $9.25 and 200-day moving average was $6.76 The short ratio stood at 0.01 indicating a short percent outstanding of 0%.

Around 5064% of the company’s stock are held by insiders while 726.9% are held by institutions.